Crinetics Pharmaceuticals Completes $63.5 Million Series B Financing

World News: . []

SAN DIEGO March 13 2018 GLOBE NEWSWIRE -- Crinetics Pharmaceuticals Inc a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers today announced it has completed a Series B financing which raised 3 6;63.5 ...

More news and information about Crinetics Pharmaceuticals, Inc.

Published By:

Globe Newswire: 18:00 GMT Tuesday 13th March 2018

Published: .

Search for other references to "crinetics" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us